Antibody drug conjugates: lessons from 20 years of clinical experience.
about
Emerging antibody-drug conjugates for treating lymphoid malignancies.Molecularly targeted therapies in cancer: a guide for the nuclear medicine physician.Targeting the seeds of small cell lung cancerDelivering natural products and biotherapeutics to improve drug efficacy.The antibody-drug conjugate target landscape across a broad range of tumour types.CYP Suppression in Human Hepatocytes by Monomethyl Auristatin E, the Payload in Brentuximab Vedotin (Adcetris®), is Associated with Microtubule Disruption.Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1.Challenges and new frontiers in analytical characterization of antibody-drug conjugates.
P2860
Q38632313-E2C183E5-330C-46BE-8CB9-C824E95A43A6Q39233197-9472150F-3FB6-460B-B06A-EBFCDF8442ADQ42314900-E8936A62-6ED1-425D-8180-4D8ADED93D68Q47419190-6F58F547-9729-46BF-8842-02FA7EAC605FQ47633328-A73583AD-C2F9-47DE-BA28-FAB0905BCEAAQ49629406-9331566D-9D90-42BD-9A34-F19E043DAE64Q50040421-913FA1B2-BDF5-4B69-BC9E-A3EF7EE86B08Q52401505-D616FD70-82F0-433C-8FC6-B2648C465C2C
P2860
Antibody drug conjugates: lessons from 20 years of clinical experience.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Antibody drug conjugates: lessons from 20 years of clinical experience.
@en
type
label
Antibody drug conjugates: lessons from 20 years of clinical experience.
@en
prefLabel
Antibody drug conjugates: lessons from 20 years of clinical experience.
@en
P2860
P356
P1433
P1476
Antibody drug conjugates: lessons from 20 years of clinical experience.
@en
P2093
A W Tolcher
P2860
P304
P356
10.1093/ANNONC/MDW424
P577
2016-10-11T00:00:00Z